Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2680]

Weight, age, and gender affect duration, intensity of toxicity for stem cell donors

Weight, age, and gender affect duration, intensity of toxicity for stem cell donors

Proteins in DNA damage response network targeted for new therapies

Proteins in DNA damage response network targeted for new therapies

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

ESMO 2012: PV-10 shows sustained response in melanoma

ESMO 2012: PV-10 shows sustained response in melanoma

Advanced surgical approaches may benefit elderly patients with colorectal, bladder cancers

Advanced surgical approaches may benefit elderly patients with colorectal, bladder cancers

ESMO 2012: New findings on optimal duration of trastuzumab therapy for women with HER2-positive early breast cancer

ESMO 2012: New findings on optimal duration of trastuzumab therapy for women with HER2-positive early breast cancer

Noninvasive measurement enables use of interstitial fluid pressure as potential biomarker for tumour aggressiveness

Noninvasive measurement enables use of interstitial fluid pressure as potential biomarker for tumour aggressiveness

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

ESMO 2012: New weapons in the fight against cancer

ESMO 2012: New weapons in the fight against cancer

ESMO 2012: Are too few women being offered breast-conserving treatment?

ESMO 2012: Are too few women being offered breast-conserving treatment?

More from ecancer